Tag Archives: generics

FDA’s Contribution to the Pricing Issue – Generic Activism

Posted on February 28, 2019 by Mark Senak

As hearings on Capitol Hill these past two months (and in the months to come) have examined the issue of pharmaceutical pricing to inform potential legislation as well as to garner attention, FDA has been addressing the issue in the … Continue reading →

Posted in Generic Drugs | Tagged , , | Comments Off on FDA’s Contribution to the Pricing Issue – Generic Activism